Clinical Trial Update: Safety and Pharmacokinetics (PK) of Raltegravir in HIV (Human Immunodeficiency Virus)-Infected Children and Adolescents [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluated safety and pharmacokinetics of raltegravir in HIV-infected children and adolescents and has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Raltegravir (raltegravir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-12-22